Xcout IntelSign inSubscribe

Aragen Life Sciences competitors & alternatives

Life SciencesIndia

The 12 closest competitors and alternatives to Aragen Life Sciences among life sciences companies — ranked by similarity to what Aragen Life Sciences actually does, not by market-cap band.

12Competitors listed

Subscribe to see Aragen Life Sciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Aragen Life Sciences

Aragen Life Sciences Ltd. is a pharmaceutical manufacturing and contract research and development organization (CRDMO) headquartered in Hyderabad, India.

Aragen Life Sciences at a glance

Aragen Life Sciences is a life sciences company headquartered in India. Its most recent funding round raised $100M in January 2025. Xcout tracks 21 named people at Aragen Life Sciences, including Anil Khubchandani (Chief Executive Officer – Development and Manufacturing Solutions).

Aragen Life Sciences leadership

  • Anil KhubchandaniChief Executive Officer – Development and Manufacturing Solutions
  • Dr. Subodh Shrinivas DeshmukhChief Executive Officer – Biologics Solutions
  • Manmahesh KantipudiManaging Director and CEO
  • Manni KantipudiMD & CEO
  • Neeraj GargCEO, Discovery Solutions
  • Sachin Anand DharapEVP and Chief Financial Officer

15 more named people on record for Aragen Life Sciences, with roles, board committees and tenure — see the full roster →

Aragen Life Sciences funding rounds

Every round on record:

DateRoundAmountInvestors
—$100M1 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 Aragen Life Sciences competitors

Ranked by semantic similarity — how close each company is to Aragen Life Sciences by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

WuXi AppTec02359 · BiotechShanghai, China
63% matchPublic

Biotech

WuXi AppTec Co., Ltd. operates as an investment holding enterprise, delivering extensive research, development, and manufacturing services. These services primarily aid in the discovery, advancement, and production of small molecule pharmaceuticals, as well as sophisticated cell and gene therapies. The company maintains a global footprint, serving clients across the People's Republic of China, other Asian territories, the United States, Europe, and various international markets. Its operations are structured across six key segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. The firm's comprehensive offerings encompass contract research, development, and manufacturing organization (CRDMO) services, supporting new drug development from initial discovery phases all the way to commercial launch. This scope extends to diverse synthetic molecular types, including small molecules, oligonucleotides, peptides, and complex conjugates. Furthermore, WuXi AppTec provides biology services and solutions that facilitate projects from target identification to candidate selection and subsequent clinical progression. The company also offers integrated drug and medical device testing services, covering everything from preclinical assessments to clinical trials. An end-to-end solution is available to expedite the market entry of cell and gene therapies, alongside specialized drug discovery services for pharmaceutical and biotechnology clients, and full-spectrum clinical research support. WuXi AppTec Co., Ltd. was established in 2000 and its headquarters are located in Shanghai, People's Republic of China.

Market cap$56.2B
Employees33,834
WuXi AppTec competitors & alternatives →
Anthem Biosciences LimitedANTHEM · BiotechBengaluru, India
68% matchPublic

Biotech

Anthem Biosciences Ltd. operates as a technology-driven organization specializing in contract research, development, and manufacturing (CRDMO). The company's activities are organized into two primary divisions: CRDMO services and the production of Specialty Ingredients. Through its CRDMO segment, Anthem Biosciences offers comprehensive, full-lifecycle support for both novel chemical and biological entities. This support spans the entire development pipeline, from initial target identification and concept generation, through preclinical evaluation, the creation of development batches for all three phases of clinical trials, and ultimately, commercial-scale manufacturing. Their expertise covers a wide array of advanced therapeutic areas, including RNA-based therapies, antibody-drug conjugates, peptides, oligonucleotides, lipids, biologics, and biotherapeutics. They also employ specialized processes such as fermentation, biosynthesis, biotransformation, and flow chemistry. In its Specialty Ingredients division, Anthem Biosciences manufactures and supplies intricate, fermentation-derived active pharmaceutical ingredients (APIs), including serratiopeptidase protease and vitamin K2. The company's portfolio also encompasses microbial and mammalian biosimilars, a diverse range of probiotics (such as various species of bacillus, lactobacillus, bifidobacterium, streptococcus, and saccharomyces boulardii), and enzymes. Additionally, they produce key peptides like semaglutide, plecanatide, linaclotide, liraglutide, and cilengitide, alongside nutritional actives, vitamin analogues, and other APIs. The company was established in Bengaluru, India, in 2006.

Market cap$5.3B
Employees2,062
Anthem Biosciences Limited competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Aragen Life Sciences and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Aragen Life Sciencesand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →